NCT03333161View on ClinicalTrials.gov

Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 2

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Infant,Premature
Interventions
DIAGNOSTIC_TEST

Cardiorespiratory monitoring

We will use high resolution physiologic monitoring of Heart Rate, Respiratory Rate, Pulse oximetry, (and near-infrared monitoring as well as microcapnography in selected infants) to evaluate control of breathing (apnea, bradycardia, desaturations).

Trial Locations (1)

35233

Regional Neonatal ICU and CCN, University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT03333161 - Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 2 | Biotech Hunter | Biotech Hunter